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Pulmonary Thromboembolectomy for Acute 
Pulmonary Thromboembolism
Inho  Yi,  M.D.*,  Joo  Chul  Park,  M.D.**,  Kyu  Seok  Cho,  M.D.**,  Bum  Shik  Kim,  M.D.**, 
Soo-Cheol  Kim,  M.D.**,  Dae  Hyun  Kim,  M.D.***,  Jung-Heon  Kim,  M.D.**,  Hyo  Chul  Youn,  M.D.**
Background:  Acute pulmonary thromboembolism is fatal because of abruptly occurring hypoxemia and right ven-
tricular failure. There are several treatment modalities, including anticoagulation, thrombolytics, ECMO (extracorporeal 
membrane oxygenator), and thromboembolectomy, for managing acute pulmonary thromboembolism. Materials and 
Methods: Medical records from January 1999 to December 2004 at our institution were retrospectively reviewed for 
pulmonary thromboembolectomy. There were 7 patients (4 men and 3 women), who underwent a total of 8 oper-
ations because one patient had post-operative recurrent emboli and underwent reoperation. Surgery was indicatedfor 
mild hypoxemia and performed with CPB (cardiopulmonary bypass) in a beating heart state. Results: The patients 
had several symptoms, such as dyspnea, chest discomfort, and palpitation. Four patients had deep vein throm-
boembolisms and 3 had psychotic problems, specifically schizophrenia. Post-operative complications included hemo-
thorax, pleural effusion, and pericardial effusion. There were two hospital deaths, one each by brain death and 
right heart failure. Conclusion: Emergency operation should be performed when medical treatments are no longer 
effective.
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INTRODUCTION
Acute  pulmonary  thromboembolism  is  a  fatal  disease  that 
can  cause  patients  to  take  a  sud d e n  t u r n  f o r  t h e  w o r s e  f r o m  
the moment of symptom manifestation due to right heart dys-
function, hypotension, and hypoxia, if there is no precise and 
fast diagnosis and treatment for it [1]. For medical therapy of 
acute pulmonary thromboembolism, we can use anticoagulants 
and  thrombolytics.  However,  when  it  comes  to  patients  who 
have unstable vital signs or for whome medical therapy is not 
indicated,  ECMO  (extracorporeal  membrane  oxygenator)  ap-
plication  and  emergent  thromboembolectomy  can  be  consi-
dered.  On  the  basis  of  the  authors’  surgeries,  we  wanted  to 
determine the indications and results of thromboembolectomy.
MATERIALS AND METHODS
Eight  patients  underwent  surgery  due  to  acute  pulmonary 
embolisms  from  January  1999  to  December  2004.  Among 
them,  we  reviewed  7  patients  who  could  be  investigated  by Inho Yi, et al
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Table 1. Characteristics of patients 
Sex Age Symptoms Combined  disease
AaDO2*
(mmHg)
DVT
† Preoperative 
heparinization
Preoperative 
inotropics
Preoperative
CPR
‡
M
F
M
M
F
M
F
23
52
25
32
39
54
68
Dyspnea
Dyspnea
Chest  discomfort, 
 S y n c o p e
Chest  pain
Palpitation
Dyspnea
Chest  pain
Nephrotic  syndrome,
  mental  retardation
Schizophrenia
CVA
§,  PFO
∥
Schizophrenia
TKR
¶,  Lt
TKR,  both
 4 2 . 9
　
 6 0 . 9
229.3
 5 2 . 6
 6 7 . 6
 6 3 . 8
O
O
O
O
O
O
O
O
O
O
O
*AaDO2=Alveolar  arterial  oxygen  difference; 
†DVT=Deep  vein  thrombosis; 
‡CPR=Cardiopulmonary  resuscitation; 
§CVA= 
Cerebrovascular  attack; 
∥PFO=Patent  foramen  ovale; 
¶TKR=Total  knee  replacement.
medical  records.  One  of  these  underwent  reoperation  due  to 
recurrence  of  pulmonary  embolism  on  the  13th  postoperative 
day. 
Patients  who  had  needed  vasopressors  for  hypotension  or 
had  shown  right  heart  dysfunction  by  echocardiography  un-
derwent  surgery.  We  performed  median  sternotomy  under 
general  anesthesia  and  then  performed  cardiopulmonary  by-
pass without cardiac arrest. After making incisions to the pul-
monary arteries longitudinally, we removed the thromboembo-
lisms  and  cautiously  compressed  both  lungs  after  opening 
both  pleurae  using  an  uncapped  Yankauer  sucker.  For  artery 
cannulation,  we  used  the  ascending  aorta  in  7  cases  and  the 
femoral  artery  in  one  case.  On  the  other  hand,  for  venous 
cannulation,  we  used  both  the  Superior  Vena  Cava  (SVC) 
and  Inferior  Vena  Cava  (IVC)  in  7  cases  and  the  femoral 
vein  in  one  case.  The  one  case  of  using  the  femoral  artery 
and  vein  was  the  patient  who  had  suffered  from  hypotension 
in  the  operating  room,  so  we  cannulated  the  femoral  artery 
and  vein  and  ran  the  CPB  first  and  then  continued  the 
surgery.  The  mean  CPB  time  was  80.5±48.9  minutes.  The 
mean  pharyngeal  temperature  was  34.4
oC  during  the  CPB 
time. 
RESULTS
The  mean  duration  from  admission  to  operation  was  3 
days,  which  included  the  cases  referred  from  other 
departments.  The  mean  age  was  41.9  years  old  (23  to  68). 
The total patients were 7 cases (4 males, 3 females). Because 
one  female  had  a  reoperation  on  the  13
th  postoperative  day, 
there  were  a  total  of  8  operations. 
The  main  symptoms  were  dyspnea  in  4  cases,  chest  pain 
and  discomfort  in  2  cases,  palpitation  in  one  case,  and  syn-
cope in one case. Four of six cases showed deep vein throm-
bosis  in  the  lower  extremity  sonography.  The  preoperative 
blood  pressure  in  5  cases  were  in  the  normal  range. 
However,  a  vasopressor  was  infused  into  the  two  patients 
who  had  suffered  from  hypotension.  The  mean  respiratory 
r a t e  w a s  2 7  b r e a t h s  p e r  m i n u t e  (22  to  36)  and  the  mean 
pulse  rate  was  113  beats  per  minute  (98  to  120).  The  body 
temperature  was  38
oC  in  one  patient  and  normal  in  the 
others.  We  diagnosed  the  disease  using  chest  computed  to-
mography and lung perfusion scan, echocardiography and pul-
monary  angiography.  In  the  chest  computed  tomography 
scans,  more  than  two  lobar  pulmonary  arteries  were  plugged 
with thromboembolisms. Echocardiography showed right heart 
dilatation  in  6  cases,  and  moderate  Tricuspid  regurgitation 
was  noted  in  3  of  them.  A  preoperative  check  of  D-dimer 
was  performed  in  4  cases,  which  were  found  to  be  elevated 
to  ＞1.0,  3.28,  1.84,  and  16.8  mcg/mL.  Troponin  I  was  ele-
vated  to  2,  2,  and  3.43  ng/mL  in  3  cases.  We  calculated  the 
difference  in  oxygen  pressure  (AaDO2)  and  the  values  were 
elevated in 6 cases (Table 1). The causes of pulmonary artery 
thromboembolism were deep vein thrombosis in 4 cases, pre-
vious  knee  transplantation  in  2,  cases  and  schizophrenia  in  2 
cases.  Of  the  remaining  cases,  one  each  was  caused  by  right Pulmonary Thromboembolectomy 
− 345  −
Table 2. Managements and outcomes of patients 
Sex Age
IVC* 
filter 
Recurrence Death
CPB 
time 
(min)
CPB
BT  (
oC)
M
F
M
M
F
M
F
23
52
25
32
39
54
68
O
O
O
O
O
O
O
 6 8
 6 0
180
 7 0
 3 8
 4 3
105
36
31
32.5
35
35
36
35.9
*IVC=Inferior  vena  cava  (IVC  filters  were  inserted  when  pa-
tients  were  transferred  from  the  intensive  care  unit  to  general 
ward  after  thromboembolectomy). 
atrial  thrombosis,  patent  foramen  ovale  (PFO)  with  cerebral 
stroke  (for  which  we  performed  thromboembolectomy  with 
PFO  primary  closure)  and  steroid  taking  due  to  renal  failure. 
There  were  two  patients  who  had  used  vasopressors  before 
surgery  and  one  of  them  underwent  cardiopulmonary  resusci-
tation.  We  infused  heparin  to  4  patients  before  surgery,  and 
we  inserted  an  IVC  filter  below  the  renal  vein  in  4  cases. 
After  that,  we  continued  anticoagulation  with  warfarin. 
The  mean  hospital  day  was  33.2  days  (16  to  67).  Hemo-
throax  occurred  in  one  case  and  was  cured  by  reoperation. 
One patient suffered from pleural and pericardial effusion, but 
went  home  without  any  special  treatment.  The  patients  who 
had a long hospital stay needed treatment for psychotic prob-
lems,  and  reoperation  made  for  a  long  hospitalization.  Two 
patients  died,  one  on  the  operative  day  and  the  other  on  the 
first  postoperative  day.  One  was  in  brain  death  after  CPR, 
and  the  other  died  of  right  heart  failure  with  myocardial 
infarction. The patient in brain death underwent the operation 
due  to  the  family’s  insistence  ( T a b l e  2 ) .  F o u r  p a t i e n t s  w h o  
came back for follow-up among the five surviving cases lived 
at  least  5  years  after  their  operations. 
DISCUSSION
Acute  pulmonary  thromboembolism  can  be  fatal.  In  our 
cases,  the  main  clinical  symptoms  were  acute  dyspnea  and 
chest comfort, and other symptoms are hypoxemia  and hypo-
tension  without  specific  previous  disease.  Twenty  percent  of 
patients  show  the  normal  range  of  arterial  oxygen  pressure 
and  the  normal  difference  between  alveolar  and  arterial  oxy-
gen  pressure  (AaDO2).  Hemodynamic  changes  can  be  shown 
in the time when 30∼50% of pulmonary arteries are plugged 
with  thrombi  [4]. 
Acute pulmonary thromboembolism can be categorized into 
massive and sub-massive groups. In massive acute pulmonary 
thromboembolism,  there  can  be  cases  of  systolic  blood  pres-
sure  below  90  mmHg,  systolic  blood  pressure  decreases  of 
more than 40 mmHg over the course of 15 minutes or more, 
and  cardiogenic  shock.  On  the  other  hand,  sub-massive  acute 
pulmonary  thromboembolism  evidences  right  heart  dysfunc-
tion  even  when  it  shows  a  hemodynamically  stable  state  [2].
The  risk  factors  of  acute  pulmonary  thromboembolism  in-
clude old age, history of deep vein thrombosis, four-limb lim-
itation  due  to  neurogenic  problems,  long  bedridden  periods 
due to cardiac or acute pulmonary injury, neoplasm, hormonal 
therapy,  congenital  or  acquired  thrombophilia,  oral  contra-
ception,  pericarditis,  and  history  of  pulmonary  thromboem-
bolism. In patients with deep vein thrombosis in the proximal 
lower  extremity  without  chest  symptoms,  pulmonary  embo-
lism  can  be  detected  in  50%  of  cases  by  a  lung  perfusion 
scan.  Seventy  percent  of  the  detected  pulmonary  throm-
boembolisms  are  combined  with  deep  vein  thrombosis  in  the 
lower extremities. Among these combined cases, limitation of 
movement  due  to  neurogenic  disease,  being  over  75  years 
old, and cardiopulmonary disease or neoplasm are risk factors 
for death by acute pulmonary thromboembolism [3,4]. Danilo 
et al. reported that moderately depressive patients with move-
ment  limitations  were  in  danger  of  pulmonary  thromboembo-
lism  [10].
The  revised  Geneva  score  can  be  used  clinically  for  pul-
monary  embolism  classification.  The  score  takes  into  account 
age  over  65  years,  history  of  arrhythmia,  thrombus  and  pul-
monary embolism, history of operation within the most recent 
one  month,  history  of  fracture,  progressive  cancer,  pain  of  a 
unilateral  lower  extremity,  hemoptysis,  heart  rate  over  75 
beats  per  minute,  pain  on  palpation  of  the  lower  extremity 
vein,  and  unilateral  edema  in  the  lower  extremity.  Clinical 
possibilities  can  be  classified  into  three  grades  (low,  inter-
mediate,  high)  according  to  the  grade  of  individual  risk 
factors.  Other  diagnostic  tools  are  chemical  tests  such  as Inho Yi, et al
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pro-BNP,  BNP,  troponin,  echocardiography,  chest  computed 
tomography,  and  lung  perfusion  scan  [4].
Echocardiography  can  reveal  the l e v e l  o f  p r e s s u r e  o v e r l o a d  
to  the  right  ventricle,  through  the  signs  of  a  diameter  ratio 
between the right and left ventricle of more than 1, right ven-
tricular  dilatation,  right  ventricular  hypokinesis,  and  the  de-
gree of ventricular septal bowing. In particular, it is said that 
the degree of ventricular septal bowing is useful in predicting 
death  [3,5].
Among  the  patients  diagnosed  with  pulmonary  throm-
boembolism,  hemodynamically  unstable  patients  should  be 
treated immediately with thrombolytics, operations, and cathe-
terized  embolectomy.  However,  hemodynamically  stable  pa-
tients  without  right  heart  dysfunction  can  be  treated  with 
anticoagulation.  If  there  is  an  abnormal  finding  of  the  right 
heart,  the  patient  can  be  treated  with  thrombolytics  under 
close  observation. 
Initial therapies include anticoagulation (unfractionated hep-
arin,  low  molecular  weight  heparin,  fondaparinux,  warfarin), 
thrombolytics,  percutaneous  thromboembolectomy,  and  oper-
ative treatment. Warfarin therapy must be continued for three 
months (Target INR: 2.0∼3.0). In the cases with risk factors 
s u c h  a s  m a l e  g e n d e r ,  o l d  a g e ,  malignancy,  and  pulmonary 
embolism without special preceding causes, however, warfarin 
therapy  must  be  continued  at  least  three  months  due  to  the 
increased  possibility  of  recurrence.  Thrombolytics  cannot  be 
used in cases of cerebral diseases, intractable hypertension, or 
within  three  weeks  post-operatively  [3].
An  IVC  filter  is  indicated  for  cases  of  contraindication  of 
anticoagulation therapy, the failure of anticoagulation therapy, 
cardiopulmonary dysfunction with arrhythmogenic thrombosis, 
high  risk  patients  for  operation  and  the  patient  taking  throm-
bolytics  due  to  proximal  arrhythmogenic  thrombosis  [6]. 
Pulmonary  thromboembolectomy  has  to  be  performed 
whenever  several  medical  treatments  do  not  show  the  effect 
in the cases of unstable blood pressure, hypoxemia, imbalance 
of electrolytes, or acidosis. If an emergency operation is diffi-
cult  to  perform,  the  application  of  ECMO  can  be  helpful  to 
maintain  survival  [8].
The  death  rate  from  pulmonary  thromboembolectomy  has 
been reported to be 20%. We can  perform  it  as fo llow s.  Th e 
first  indication  is  the  case  of  confirmed  massive  pulmonary 
thromboembolism  with  hemodynamic  changes.  In  this  case, 
right  heart  dysfunction  or  the  need  for  vasopressors  becomes 
evident.  The  second  one  is  hemodynamic  instability  such  as 
shock, in spite of heparin infusion or supportive care for sta-
ble  vital  signs.  The  last  one  is  the  case  of  a  contraindication 
or  intractable  state  of  anticoagulation  [7].  If  there  is  a  mas-
sive thrombus in the proximal lower limb and a percutaneous 
thromboembolectomy  using  a  catheter  cannot  be  performed, 
an operation has to be considered even though the vital signs 
are  stable  [9].
CONCLUSION
Although noninvasive therapies such as anticoagulation and 
thrombolytics  tend  to  gradually  replace  surgical  interventions, 
in  light  of  this  study,  we  suggest  that  emergency  pulmonary 
thromboembolectomies  are  needed  for  patients  who  are  in  a 
hemodynamically unstable state or have a right heart dysfunc-
tion.  Furthermore,  patients  whose  movements  are  limited  due 
to  psychotic  problems  are  in  danger  of  pulmonary  throm-
boembolism. Therefore, careful observation of such patients is 
necessary. 
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